DexCom, Inc. (DXCM)
NASDAQ: DXCM · IEX Real-Time Price · USD
138.01
+0.14 (0.10%)
At close: Apr 25, 2024, 4:00 PM
130.00
-8.01 (-5.80%)
After-hours: Apr 25, 2024, 7:59 PM EDT
DexCom Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for DexCom stock have an average target of 140.79, with a low estimate of 100 and a high estimate of 165. The average target predicts an increase of 2.01% from the current stock price of 138.01.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DexCom stock from 14 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 7 | 7 | 7 | 7 | 6 | 6 |
| Hold | 3 | 3 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 15 | 15 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Strong Buy Maintains $153 → $163 | Strong Buy | Maintains | $153 → $163 | +18.11% | Apr 10, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $148 → $161 | Strong Buy | Maintains | $148 → $161 | +16.66% | Apr 3, 2024 |
| RBC Capital | RBC Capital | Buy Initiates $165 | Buy | Initiates | $165 | +19.56% | Mar 12, 2024 |
| Raymond James | Raymond James | Strong Buy Maintains $147 → $151 | Strong Buy | Maintains | $147 → $151 | +9.41% | Jan 23, 2024 |
| Raymond James | Raymond James | Strong Buy Maintains $131 → $147 | Strong Buy | Maintains | $131 → $147 | +6.51% | Jan 3, 2024 |
Financial Forecast
Revenue This Year
4.41B
from 3.62B
Increased by 21.80%
Revenue Next Year
5.25B
from 4.41B
Increased by 18.99%
EPS This Year
1.78
from 1.30
Increased by 37.24%
EPS Next Year
2.27
from 1.78
Increased by 27.40%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.6B | 5.6B | 6.7B | 8.0B | 9.4B |
| Avg | 4.4B | 5.3B | 6.2B | 7.3B | 8.3B |
| Low | 4.2B | 4.9B | 5.6B | 6.7B | 7.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 26.6% | 26.1% | 26.9% | 28.9% | 29.5% |
| Avg | 21.8% | 19.0% | 17.9% | 17.7% | 14.6% |
| Low | 15.3% | 10.9% | 7.3% | 8.2% | 2.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.97 | 2.64 | 3.28 | 4.02 | 4.78 |
| Avg | 1.78 | 2.27 | 2.83 | 3.91 | 4.64 |
| Low | 1.54 | 1.95 | 2.36 | 3.75 | 4.46 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 51.8% | 47.7% | 44.1% | 42.0% | 22.3% |
| Avg | 37.2% | 27.4% | 24.6% | 37.9% | 18.8% |
| Low | 18.4% | 9.3% | 3.9% | 32.5% | 14.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.